Home
Hannah Valantine, Director: BridgeBio Pharma BBIO Planned sale · Filed 06/22
Trade details
- Type
- Planned sale notice
- Person
- Hannah ValantineDirector
- Planned sale date
- 26/06/22
- Filed
- 26/06/22
$190.9K to be sold
BridgeBio Pharma trades, last 26 weeks
What else happened in BridgeBio Pharma around then
Filed or reported within 30 days of the trade day · 05/23~07/22Hannah Valantine's recent trades
- Hannah Valantine
Planned sale10b5-1 planCareDx
Planned sale10b5-1 planCareDx
CDNA
$856.2K
28,779 sh
$856.2K
Filed 07/16
Traded 07/16
- Hannah Valantine
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 planBridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/24
Traded 06/22
- Hannah Valantine
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 planBridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/24
Traded 06/23
- Hannah Valantine
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 planBridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/23
Traded 06/23
- Hannah Valantine
Sell10b5-1 planCareDx
Sell10b5-1 planCareDx
CDNA
$279.7K
12,103 sh
$279.7K
Filed 06/16
Traded 06/15
